In the BioHarmony Drug Report Database
Alosetron
Lotronex, Aloxi (alosetron) is a small molecule pharmaceutical. Alosetron was first approved as Lotronex on 2000-02-09. It is used to treat abdominal pain, diarrhea, and irritable bowel syndrome in the USA. It has been approved in Europe to treat nausea, neoplasms, and vomiting. It is known to target 5-hydroxytryptamine receptor 3A.
Trade Name
|
Aloxi |
|---|---|
Common Name
|
alosetron |
ChEMBL ID
|
CHEMBL1110 |
Indication
|
abdominal pain, diarrhea, irritable bowel syndrome, nausea, neoplasms, vomiting |
Drug Class
|
Serotonin 5-HT3 antagonists |
Image (chem structure or protein)